Predictors of the degree of drug treatment coverage for injection drug users in 94 metropolitan areas in the United States of America

International Journal of Drug Policy

Volumn 18, Issue 6, 2007, Pages 475-485

  Friedman, Samuel R ^a,b   Tempalski, Barbara ^a   Brady, Joanne E ^a   Friedman, Judith J ^c   Cooper, Hannah L F ^a,d   Flom, Peter L ^a   McGrath, Moriah M ^a   Gostnell, Karla ^a   Des Jarlais, Don C ^a,e  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d Columbia University ^*  (United States)

^e BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Community action; Drug use treatment; Harm reduction; Health services; Injection drug users; Metropolitan areas; Treatment coverage

Indexed keywords

METHADONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONSUMER ADVOCACY; CONTROLLED STUDY; DRUG ABUSE; DRUG INJECTION VOLUME; DRUG USE; EPIDEMIOLOGICAL DATA; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PREDICTOR VARIABLE; PRIORITY JOURNAL; SOCIOECONOMICS; UNITED STATES;

COMMUNITY HEALTH SERVICES; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; FORECASTING; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; POLITICS; REGRESSION ANALYSIS; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES; URBAN HEALTH SERVICES;

EID: 36549047477     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2006.10.004     Document Type: Article

References (77)

1. Anderson W. The New York needle trial: The politics of public health in the age of AIDS. American Journal of Public Health 81 (1991) 1506-1517
2. AIDS Public Information Data Set (data through 2002) (2002). [Data file]. Centers for Disease Control and Prevention. Atlanta, GA: Centers for Disease Control and Prevention.
3. Banzhaf M., Morgan T., and Ramspacher K. Reproductive rights and AIDS: The connection. In: Banzhaf M., et al. (Ed). Women, AIDS & activism (1992), South End Press, Boston, MA
4. Bertram E., Blachman M., Sharpe K., and Andreas P. Drug War Politics (1996), University of California Press, Los Angeles
5. Beth Israel Medical Center. Beth Israel national survey of syringe exchange programs (2000), Beth Israel Medical Center, New York
6. Brown B.S., and Beschner G.M. Handbook on risk of AIDS: Injection drug users and sexual partners (1993), Greenwood Press, Westport, CT
7. Brown P., Mayer B., Zavestoski S., Luebke T., Mandelbaum J., and McCormick S. The health politics of asthma: Environmental justice and collective illness experience in the United States. Social Science and Medicine 57 (2003) 453-464
8. Brown P., Zavestoski S., McCormick S., Mayer B., Morello-Frosch R., and Gasior R. Embodied health movements: New approaches to social movements in health. Sociology of Health and Illness 26 1 (2004) 50-80
9. Chen X., Ender P., Mitchell M., von Eyben R., and Wells C. SAS web books: Regression with SAS (2006), University of California, Los Angeles
10. Cohen C.J. The boundaries of blackness: AIDS and the breakdown of Black politics (1999), University of Chicago Press, Chicago
11. Cooper H.L.F. Medical theories of opiate addiction's etiology and their relationship to addicts' perceived social position in the United States: An historical analysis. International Journal of Drug Policy 15 (2004) 435-445
12. Cooper, H. L. F., Friedman, S. R., Tempalski, B. J., & Friedman, R. (in press). Residential segregation and the prevalence of injection drug use among Black adult residents of US metropolitan areas. American Journal of Public Health.
13. Crain R.L. The politics of school desegregation (1968), Aldine, Chicago
14. Cutler D.M., and Glaeser E.L. Are ghettoes good or bad?. Quarterly Journal of Economics 112 (1997) 827-872
15. DeMarco R., and Johnsen C. Taking action in communities: Women living with HIV/AIDS lead the way. Journal of Community Health Nursing 20 1 (2003) 51-62
16. Des Jarlais D.C., Paone D., Friedman S.R., Peyser N., and Newman R.G. Public health then and now: Regulating controversial programs for unpopular people: Methadone maintenance and syringe-exchange programs. American Journal of Public Health 85 11 (1995) 1577-1584
17. Ellen I.G. Is segregation bad for your health?. In: Gale W.G., and Pack J.R. (Eds). Papers on urban affairs (2000), Brookings Institution Press, Washington, DC 203-238
18. Everitt B.S. The Cambridge dictionary of statistics. 2nd ed. (2002), Cambridge University Press, Cambridge, UK
19. Falco M. US federal drug policy. In: Lowinson J.H., Ruiz P., Millman R.B., and Langrod J.G. (Eds). Substance abuse: A comprehensive textbook (2005), Lippincott/Williams & Wilkins, New York 21-32
20. Farley T.A. Sexually transmitted diseases in the southeastern United States: Location, race, and social context. Sexually Transmitted Diseases 33 7 (2006) S58-S64
21. Friedman J.J. Structural constraints on community action: The case of infant mortality rates. Social Problems 21 2 (1973) 230-245
22. Friedman J.J. Central business district and residential urban renewal: Response to undesired change?. Social Science Quarterly 58 (1977) 45-49
23. Friedman J.J. Community action on water pollution. Human Ecology 5 (1977) 329-353
24. Friedman J.J. The importance of specific resources to community actions: The case of foreign trade zones. Social Science Quarterly 71 (1990) 602-618
25. Friedman J.J. The effects of industrial structure and resources upon the distribution of fast-growing small firms among US urbanised areas. Urban Studies 32 (1995) 863-883
26. Friedman S.R. HIV-related politics in long-term perspective. AIDS Care 10 Suppl. 2 (1998) S93-S103 (Notes: CDUHR Staff)
27. Friedman S.R. The political economy of drug-user scapegoating-and the philosophy and politics of resistance. Drugs: Education, Prevention, and Policy 5 1 (1998) 15-32
28. Friedman S.R., Jose B., Deren S., Des Jarlais D.C., and Neaigus A. Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. American Journal of Epidemiology 142 8 (1995) 864-874
29. Friedman S.R., Curtis R., Neaigus A., Jose B., and Des Jarlais D.C. Social networks, drug injectors' lives and HIV/AIDS (1999), Plenum, New York
30. Friedman S.R., Tempalski B., Perlis T., Keem M., Friedman R., Flom P., et al. Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users. Journal of Urban Health 81 3 (2004) 377-400
31. Friedman S.R., Cooper H.L.F., Tempalski B.J., Friedman R., Flom P.L., and Des Jarlais D.C. Relationships of deterrence and law enforcement to drug-related harms among drug injectors in USA metropolitan areas. AIDS 20 (2006) 93-99
32. Grattet R., Jenness V., and Curry T. The homogenization and differentiation of hate crime law in the United States, 1978-1995: Innovation and diffusion in the criminalization of bigotry. American Sociological Review 63 (1998) 286-307
33. Hoffman B. Health care reform and social movements in the United States. American Journal of Public Health 93 1 (2003) 75-85
34. Holmberg S.D. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. American Journal of Public Health 86 5 (1996) 642-654
35. Hubbard R.L., Marsden M.E., Cavanaugh E., Rachal J.V., and Ginzburg H.M. Role of drug-abuse treatment in limiting the spread of AIDS. Review of Infectious Disease 10 2 (1988) 377-384
36. Hubbard R.L., Craddock S.G., and Anderson J. Overview of 5-year follow-up outcomes in the Drug Abuse Treatment Outcomes Studies (DATOS). Journal of Substance Abuse Treatment 25 3 (2003) 125-134
37. Huber P.J. Robust regression: Asymptotics, conjectures, and Monte Carlo. Annals of Statistics 1 (1973) 799-821
38. Institute of Medicine. (1998). Bridging the gap between practice and research: Forging partnerships with community-based drug and alcohol treatment. Washington, DC: National Academies Press.
39. Jackson S., Anderson R., Johnson N., and Sorlie P. The relation of residential segregation to all-cause mortality: A study in Black and White. American Journal of Public Health 90 (2000) 1480-1482
40. Joseph H., and Appel P. Alcoholism and methadone treatment: Consequences for the patient and the program. American Journal of Drug and Alcohol Abuse 11 (1985) 37-53
41. Kuha J. AIC and BIC: Comparisons of assumptions and performance. Sociological Methods and Research 33 (2004) 188-229
42. Kwiatkowski C.F., Booth R.E., and Lloyd L.V. The effects of offering free treatment to street-recruited opioid injectors. Addiction 95 5 (2000) 697-704
43. Lewis Mumford Center. Dimensions of segregation (2003), Lewis Mumford Center for Comparative Regional and Urban Research, University at Albany, Albany, NY
44. Metzger D.S., Navaline H., and Woody G.E. Drug abuse treatment as AIDS prevention. Public Health Reports 113 Suppl. 1 (1998) 97-106
45. Musto D. The American disease: Origins of narcotic control (1973), Yale University Press, New Haven, CT
46. National Institute on Drug Abuse [NIDA]. Cooperative agreement for AIDS community-based outreach/intervention research program (2001), National Institutes of Health [NIH], Rockville, MD
47. Office of Management and Budget. Standards for defining metropolitan and micropolitan statistical areas. Federal Register 65 (2000) 8228-8238
48. Petchey R., Williams J., Farnsworth B., and Starkey K. A tale of two (low prevalence) cities: Social movement organisations and the local policy response to HIV/AIDS. Social Science & Medicine 47 9 (1998) 1197-1208
49. Polednak A.P. Black-White differences in infant mortality in 38 standard metropolitan statistical areas. American Journal of Public Health 81 11 (1991) 1480-1482
50. Polednak A.P. Poverty, residential segregation, and Black/White mortality ratios in urban areas. Journal of Health Care for the Poor and Underserved 4 4 (1993) 363-373
51. Polednak A.P. Segregation, poverty and mortality in urban African Americans (1997), Oxford University Press, New York
52. Rich C.L., Dhossche D.M., Ghani S., and Isacsson G. Suicide methods and presence of intoxicating abusable substances: Some clinical and public health implications. Annals of Clinical Psychiatry 10 4 (1998) 169-175
53. Ronchetti E. Robustness aspects of model choice. Statistica Sinica 7 (1997) 327-338
54. ® 9.1 user's guide (2004), SAS Institute, Cary, NC
55. Sheppard V.B., Hannon P.M., Barbosa C.E., and Pestian J.P. From research to community action: An assessment of child and adolescent hospitalizations. Family and Community Health 22 (1999) 16-17
56. Simpson D.D., and Sells S. Opioid addiction and treatment: A 12-year follow-up (1990), Krieger, Malibar, FL
57. Subramanian S.V., Acevedo-Garcia D., and Osypuk T.L. Racial residential segregation and geographic heterogeneity in Black/White disparity in poor self-rated health in the US: A multilevel statistical analysis. Social Science & Medicine 60 (2005) 1667-1679
58. Teeple G. Globalization and the decline of social reform (1995), Humanities Press, New Jersey
59. Tempalski, B. (2005). The uneven geography of syringe exchange programs in the United States: Need, politics, and place. Unpublished doctoral dissertation. Department of Geography, University of Washington.
60. Tempalski B., Friedman S.R., Des Jarlais D.C., McKnight C., Keem M., and Friedman R. What predicts which US metropolitan areas have syringe exchanges?. International Journal of Drug Policy 14 (2003) 124-417
61. Tempalski, B., Flom, P. L., Friedman, S. R., Des Jarlais, D. C., Friedman, J. J., McKnight, C., Friedman, R. (in press). Social and Political Factors Predicting the Presence of Syringe Exchange Programs in 96 Metropolitan Areas in the United States. American Journal of Public Health.
62. Thorpe L.E., Bailey S.L., Huo D., Monterroso E.R., and Ouellet L.J. Injection-related risk behaviors in young urban and suburban injection drug users in Chicago (1997-1999). Journal of Acquired Immune Deficiency Syndromes 27 (2001) 71-78
63. Turk H. Organizations in modern life (1977), Jossey-Bass, Washington, DC
64. Bureau of the Census. United States census annual surveys of government finances (1992), US Census Bureau, Washington, DC
65. US Department of Justice. Uniform crime reporting program data [United States]: County-level detailed arrest and offense data, 1994. Federal Bureau of Investigation (producer). 3rd ICPSR ed. (2001), Inter-University Consortium for Political and Social Research, Ann Arbor, MI
66. Department of Justice. Uniform crime reporting program data [United States]: County-level detailed arrest and offense data, 1995. Federal Bureau of Investigation (producer). 2nd ICPSR ed. (2001), Inter-University Consortium for Political and Social Research, Ann Arbor, MI
67. Department of Justice. Uniform crime reporting program data [United States]: County-level detailed arrest and offense data, 1996. Federal Bureau of Investigation (producer). 3rd ICPSR ed. (2001), Inter-University Consortium for Political and Social Research, Ann Arbor, MI
68. Department of Justice. Uniform crime reporting program data [United States]: County-level detailed arrest and offense data, 1997. Federal Bureau of Investigation (producer). 2nd ICPSR ed. (2001), Inter-University Consortium for Political and Social Research, Ann Arbor, MI
69. US Department of Health and Human Services. Office of Applied Studies, Substance Abuse and Mental Health Services Administration [SAMHSA]. Uniform facility data set (UFDS): 1997-data on substance abuse treatment facilities. 2nd ICPSR ed. (2004), National Survey of Substance Abuse Treatment Services (N-SSATS) Series: Inter-university Consortium for Political and Social Research, Ann Arbor, MI
70. Wallace D., and Wallace R. A plague on your houses (1998), Verso, New York
71. Wenger L.D., and Rosenbaum M. Drug treatment on demand-not. Journal of Psychoactive Drugs 26 (1994) 1-11
72. Witko C., and Newmark A.J. Business mobilization and public policy in the US states. Social Science Quarterly 86 (2005) 356-357
73. Wohl A.R., Lu S., Odem S., Sorvillo F., Pegues C.F., and Kerndt P.R. Sociodemographic and behavioral characteristics of African-American women with HIV and AIDS in Los Angeles County, 1990-1997. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 19 4 (1998) 413-420
74. Yohai V. High breakdown point and high efficiency robust estimates for regression. Annals of Statistics 48 (1987) 642-656
75. Zanis D.A., and Woody G.E. One-year mortality rates following methadone treatment discharge. Drugs and Alcohol Dependence 52 (1998) 257-260
76. Zerai A., and Banks R. Dehumanizing discourse, anti-drug law, and policy in America: A "crack mother's" nightmare (2002), Ashgate, Burlington, VT
77. Zule W.A., and Desmond D.P. Factors predicting entry of injecting drug users into substance abuse treatment. American Journal of Drug and Alcohol Abuse 26 2 (2000) 247-261